COSCIENS Biopharma Inc. Adjustments For Increase Decrease In Other Liabilities
COSCIENS Biopharma Inc. (CSCIF) reported Adjustments For Increase Decrease In Other Liabilities of $6.00 thousand for the 3-month period ending 2023-09-30, per its 6-K filed 2023-11-09.
Discontinued › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities · last filed 2024-05-16
- COSCIENS Biopharma Inc. adjustments for increase decrease in other liabilities for the quarter ending 2023-09-30 was $6.00K.
- COSCIENS Biopharma Inc. adjustments for increase decrease in other liabilities for the quarter ending 2023-06-30 was -$4.00K.
- COSCIENS Biopharma Inc. adjustments for increase decrease in other liabilities for the quarter ending 2023-03-31 was -$9.00K.
- COSCIENS Biopharma Inc. adjustments for increase decrease in other liabilities for the quarter ending 2019-03-31 was -$20.00K.
| Period end | Adjustments For Increase Decrease In Other Liabilities 3 month | Adjustments For Increase Decrease In Other Liabilities 3 month as first filed | Adjustments For Increase Decrease In Other Liabilities 6 month | Adjustments For Increase Decrease In Other Liabilities 9 month | Adjustments For Increase Decrease In Other Liabilities 12 month | Adjustments For Increase Decrease In Other Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-09-30 | $6.00K 6-K · filed 2023-11-09 | $2.00K derived: sum of 2 quarters · filed 2023-11-09 | $11.00K 6-K · filed 2023-11-09 | |||
| 2023-06-30 | -$4.00K 6-K · filed 2023-08-09 | $5.00K 6-K · filed 2023-08-09 | ||||
| 2023-03-31 | -$9.00K 6-K · filed 2024-05-16 | $9.00K 6-K · filed 2023-05-09 | ||||
| 2022-12-31 | $2.00K 20-F/A · filed 2024-02-15 | |||||
| 2019-12-31 | -$389.00K 20-F · filed 2022-03-29 | |||||
| 2019-03-31 | -$20.00K 6-K/A · filed 2020-05-11 | -$1.44M derived: sum of 2 quarters · filed 2020-05-11 | -$1.70M derived: sum of 3 quarters · filed 2020-05-11 | -$1.91M derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | -$1.42M derived: 20-F 12 month − 6-K 9 month · filed 2020-03-31 | -$1.68M derived: sum of 2 quarters · filed 2020-03-31 | -$1.89M derived: sum of 3 quarters · filed 2020-03-31 | -$1.96M 20-F · filed 2020-03-31 | ||
| 2018-09-30 | -$253.00K 6-K · filed 2019-11-07 | -$470.00K derived: sum of 2 quarters · filed 2019-11-07 | -$533.00K 6-K · filed 2019-11-07 | |||
| 2018-06-30 | -$217.00K 6-K · filed 2019-08-13 | -$280.00K 6-K · filed 2019-08-13 | ||||
| 2017-12-31 | -$435.00K 20-F · filed 2020-03-31 | -$212.00K 20-F · filed 2018-03-28 | ||||
| 2016-12-31 | -$231.00K 20-F · filed 2018-03-28 | |||||
| 2015-12-31 | -$252.00K 20-F · filed 2018-03-28 |